BGI
Birks Group Inc.·Consumer Cyclical
0.73
4.675%(−0.04)
Market ClosedLast Updated: — ET
52W L: $0.5652W H: $1.57
BGI NEWS
defenseworld.net
Mar 13
Birks Group (NYSE:BGI) Trading Down 0.9% – Here’s Why
Shares of Birks Group Inc. (NYSE: BGI - Get Free Report) traded down 0.9% on Thursday. The company traded as low as $0.68 and last traded at $0.6910. 3,912 shares were traded during mid-day trading, a decline of 88% from the average session volume of 33,686 shares. The stock had previously closed at $0.6975. Birks
businesswire.com
Feb 10
Birks Group Announces the Retirement and New Appointment of Its CFO
MONTREAL--(BUSINESS WIRE)--Birks Group Inc. (the “Company” or “Birks Group”) (NYSE American: BGI) announced today that Katia Fontana, Vice President and Chief Financial Officer, has decided to retire, effective April 1, 2026. Over the last six years, Ms. Fontana has been an integral member of the senior management team, helping guide the Company through strategic transformations and external challenges with professionalism and steady leadership. Birks Group is also pleased to announce that Mr.
businesswire.com
Jan 29
Birks Group Reports FY2026 Holiday Period Sales Results
MONTREAL--(BUSINESS WIRE)--Birks Group Inc. (the “Company” or “Birks Group”) (NYSE American: BGI), today reported its sales results for the 8-week interim sales period ended December 27th, 2025 (the “FY2026 Holiday Period”), resulting in an increase of 11.8% in net sales as compared to the corresponding period in FY2025. Comparable store sales for the FY2026 Holiday Period increased by 2.5% as compared to the corresponding period in FY2025. The 11.8% increase in net sales for the FY2026 Holiday.
reuters.com
Jan 13
BGI, Roche roll out diagnostic tests for Alzheimer's in China
BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort to expand access to easier-to-use diagnosis and monitoring choices for patients with the brain-wasting condition.
